CLINICAL_TRIALS
trial_result
· 2023-12-14
Clinical Trial Update: A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis [Phase 2]
Summary
A phase 2 trial tested whether BI 655130 (spesolimab) can prevent flare-ups in generalized pustular psoriasis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Generalized Pustular Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2023-12-14